Scilex Holding (SCLXW) Cost of Revenue (2022 - 2026)

Scilex Holding (SCLXW) recorded quarterly Cost of Revenue of $4.4 million in Q1 2026, up 70.12% quarter-over-quarter from $2.6 million in Q4 2025, and up 221.32% on a YoY basis from $1.4 million in Q1 2025.

Scilex Holding (SCLXW) Cost of Revenue (2022 - 2026) Analysis & Trends

Scilex Holding's Cost of Revenue history runs 5 years deep, the most recent figure standing at $4.4 million for Q1 2026.

  • In Q1 2026, Cost of Revenue rose 221.32% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $13.7 million (down 4.01% YoY), while the FY2025 annual figure was $10.6 million, down 36.49% from the prior year.
  • Cost of Revenue was $4.4 million for Q1 2026 at Scilex Holding, up from $2.6 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $4.7 million in Q4 2024 to a low of $1.1 million in Q1 2022.
  • Historically, Cost of Revenue has averaged $3.4 million across 5 years, with a median of $3.6 million in 2022.
  • The sharpest annual moves came in 2025 and 2026: Cost of Revenue plunged 63.96% in 2025, then jumped 221.32% in 2026.
  • A 5-year view of Cost of Revenue shows it stood at $4.5 million in 2022, then advanced by 0.18% to $4.5 million in 2023, then climbed by 3.76% to $4.7 million in 2024, then sank by 44.28% to $2.6 million in 2025, then soared by 70.12% to $4.4 million in 2026.
  • The last three Cost of Revenue figures came in at $4.4 million (Q1 2026), $2.6 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 2.53 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 3.58 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 8.11 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 4.22 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 4.20 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 2.74 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 1.45 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 3.55 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 3.42 Bn
10 Scilex Holding - - 4.15 Mn 4.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.45 Mn
Mar 31, 2026 4.45 Mn
Dec 31, 2025 2.61 Mn
Dec 31, 2025 2.61 Mn
Sep 30, 2025 3.33 Mn
Sep 30, 2025 3.33 Mn
Jun 30, 2025 3.27 Mn
Jun 30, 2025 3.27 Mn
Mar 31, 2025 1.38 Mn
Mar 31, 2025 1.38 Mn
Dec 31, 2024 4.69 Mn
Dec 31, 2024 4.69 Mn
Sep 30, 2024 3.77 Mn
Sep 30, 2024 3.77 Mn
Jun 30, 2024 4.39 Mn
Jun 30, 2024 4.39 Mn
Mar 31, 2024 3.84 Mn
Mar 31, 2024 3.84 Mn
Dec 31, 2023 4.52 Mn
Dec 31, 2023 4.52 Mn